Replies to post #17974 on Positron Corporation (POSC)

[ipotter]

You're right. We can't accurately value the company, imo.

Found it interesting that a report in April said radiopharma market will be $5.5B by 2017 and pointed to shortage of Tc-99m and reactor shutdowns as being a threat to the industry.

Then a report earlier this month said radiopharma market will be $12.2B by 2018 and basically stated Tc-99m is currently the most widely used radioisotope in medical application, but that is changing. Newer generators (PET generators) should see double-digit growth.

What I take from that is PET is going to grow substantially in the coming years. Radiopharma will be important to Positron's growth. But Positron is more than a radiopharma company.

http://www.auntminnie.com/index.aspx?sec=sup&sub=mol&pag=dis&ItemID=102995

http://www.auntminnie.com/index.aspx?d=1&sec=sup&sub=mol&pag=dis&ItemID=103958